Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Century Therapeutics, Inc.IPSC · Entity 5739 | SVP Finance & Operations | September 14, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Century Therapeutics, Inc.
Report date September 14, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 502,907 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 1,658 · Balance 502,907 F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 15, 2026 22:25 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 1,658 | $1.93 | $3,199.94 |
DisclosureSEC source: 0001867173-26-000020 · form4-09152026_100903.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,907 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 20:34 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 254 | $2.05 | $520.70 |
DisclosureSEC source: 0001867173-26-000018 · form4-09092026_080900.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,565 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:08 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 275 | $1.98 | $543.68 |
DisclosureSEC source: 0001867173-26-000016 · form4-08052026_080803.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,819 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 23:56 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 1,654 | $2.23 | $3,691.73 |
DisclosureSEC source: 0001867173-26-000014 · form4-06152026_110627.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 505,094 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:10 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 249 | $2.11 | $525.64 |
DisclosureSEC source: 0001867173-26-000012 · form4-06092026_040605.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,748 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| May 04, 2026 Filed May 6, 2026 21:27 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 264 | $2.34 | $618.02 |
DisclosureSEC source: 0001867173-26-000010 · form4-05062026_090521.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,997 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:04 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 7,043 | $2.55 | $17,952.61 |
DisclosureSEC source: 0001867173-26-000008 · form4-03162026_080351.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,261 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:10 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 247 | $2.54 | $626.39 |
DisclosureSEC source: 0001867173-26-000006 · form4-03112026_080344.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,304 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:14 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 323 | $1.82 | $588.51 |
DisclosureSEC source: 0001867173-26-000004 · form4-02052026_090230.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,551 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001867173-26-000002 · form4-02042026_090202.xml · derivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2036-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001867173-26-000002 · form4-02042026_090202.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,874 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:34 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 257 | $0.53 | $136.72 |
DisclosureSEC source: 0001867173-25-000005 · form4-12102025_091245.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,874 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:01 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 292 | $0.59 | $171.11 |
DisclosureSEC source: 0001867173-25-000003 · form4-11052025_091147.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,131 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:34 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 263 | $0.50 | $131.50 |
DisclosureSEC source: 0001062993-25-015526 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,423 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:13 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 296 | $0.53 | $158.06 |
DisclosureSEC source: 0001062993-25-013720 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,686 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:05 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 4,904 | $0.62 | $3,050.29 |
DisclosureSEC source: 0001062993-25-011429 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,982 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:38 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 295 | $0.55 | $162.25 |
DisclosureSEC source: 0001062993-25-008772 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,886 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:26 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 95,625 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · derivative · entry 3 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,625 Underlying: Common Stock · 95,625 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:26 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 95,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,181 F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:26 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 1,240 | $0.62 | $762.60 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,556 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 22:30 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 351 | $0.78 | $273.78 |
DisclosureSEC source: 0001062993-25-001755 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,796 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:59 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 283 | $1.23 | $347.24 |
DisclosureSEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,147 F2 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:59 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | Tax withholdingCommon Stock | 16,611 | $1.26 | $20,929.86 |
DisclosureSEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,430 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:06 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 289 | $1.83 | $528.00 |
DisclosureSEC source: 0001062993-24-014582 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,041 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:36 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 17,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-012312 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,330 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 100% on June 7, 2025, subject the Reporting Person's continued service through such vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| May 03, 2024 Filed May 7, 2024 21:13 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 257 | $3.11 | $798.24 |
DisclosureSEC source: 0001062993-24-009574 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,323 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 23:38 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 81,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001062993-24-006185 · form4.xml · derivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 81,000 shares Expires 2034-03-07 F2 · derivative.exercise_date: The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 23:38 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006185 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,580 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 22:21 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 557 | $4.49 | $2,499.26 |
DisclosureSEC source: 0001062993-24-002321 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,580 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:21 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | SaleCommon Stock | 643 | $3.84 | $2,469.76 |
DisclosureSEC source: 0001062993-24-002321 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,137 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:04 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | Tax withholdingCommon Stock | 16,611 | $1.49 | $24,750.39 |
DisclosureSEC source: 0001062993-23-020090 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,780 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:33 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 120,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011404 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,391 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs shall vest 50% on November 1, 2023, with the remaining 50% vesting upon the earlier of: (i) November 1, 2024; and (ii) satisfaction of certain performance criteria, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:52 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001062993-23-002311 · form4.xml · derivative · entry 4 Carr Douglas · CIK 0001867173 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:52 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001062993-23-002311 · form4.xml · derivative · entry 3 Carr Douglas · CIK 0001867173 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:52 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-002311 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,545 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 23:52 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-002311 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,045 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:49 UTC | Century Therapeutics, Inc. IPSC · Entity 5739 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001684 · form4.xml · derivative · entry 1 Carr Douglas · CIK 0001867173 · VP of Finance and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.